Serologic evidence of Toxoplasma gondii infection among cancer patients. A prospective study from Qassim region, Saudi Arabia

References

1. ↵
   1. Flegr J,
   2. Prandota J,
   3. Soickova M,
   4. Ispaili ZH

   (2014) Toxoplasmosis: A global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS ONE 9:e90203.

   OpenUrlCrossRefPubMed
2. ↵
   1. Havelaar AH,
   2. Haagsma JA,
   3. Manjen MJ,
   4. Kemmeren JM,
   5. Verhoef LP,
   6. Vijgen SM,
   7. et al.

   (2012) Disease burden of foodborne pathogens in the Netherlands. Intl J Food Microbiol 156:231–238.

   OpenUrl
3. ↵
   1. Coben SB,
   2. Denkers EY

   (2015) The gut mucosal immune response to Toxoplasma gondii. Parasite Immunol 37:108–117.

   OpenUrlCrossRefPubMed
4. ↵
   1. Yazar S,
   2. Yaman O,
   3. Eser B,
   4. Altuntas F,
   5. Kurnaz F,
   6. Sahin E

   (2004) Investigation of anti-Toxoplasma antibodies (IgG and IgM) in patients with neoplasia. J Med Microbiol 53:1183–1186.

   OpenUrlPubMed
5. ↵
   1. Vogel CL,
   2. Lunde MN

   (1969) Toxoplasma serology in patients with malignant diseases of the reticuloendothelial system. Cancer 23:614–618.

   OpenUrlPubMed
6. ↵
   1. Elshahawi IS,
   2. Khalil MI,
   3. Bahnass MM

   (2014) Seroprevalence of Toxoplasma gondii infection in women in Najran city, Saudi Arabia. Saudi Med J 35:1143–1146.

   OpenUrl
7. 1. Almogren A

   (2011) Antenatal screening for Toxoplasma gondii infection at a tertiary care hospital in Riyadh, Saudi Arabia. Ann Saudi Med 31:569–572.

   OpenUrlPubMed
8. 1. Ertug S,
   2. Okyay P,
   3. Turkmen M,
   4. Yuksel H

   (2005) Seroprevalence and risk factors for Toxoplasma gondii infection among pregnant women in Aydin province, Turkey. BMC Public Health 15:66.

   OpenUrl
9. 1. Imam A,
   2. Almansour MA

   (2015) Serologic evidence of Toxoplasma gondii infection among pregnant women in Qassim region, Saudi Arabia. Pak J Med Res 54:84–86.

   OpenUrl
10. ↵
    1. Shin DW,
    2. Cha DY,
    3. Hua QJ,
    4. Cha GH,
    5. Lee YH

    (2009) Seroprevalence of Toxoplasma gondii infection and characteristics of seropositive patients in general hospitals in Daejeon, Korea. Korean J Parasitol 47:125–130.

    OpenUrlCrossRefPubMed
11. ↵
    1. Nimir A,
    2. Othman A,
    3. Ese S,
    4. Musa Z,
    5. Majid IA,
    6. Kamarudin Z,
    7. et al.

    (2010) Latent toxoplasmosis in patients with different malignany: A hospital based study. J Clin Med Res 23:117–120.

    OpenUrl
12. ↵
    1. Cong W,
    2. Liu GH,
    3. Meng QF,
    4. Dong W,
    5. Qin SY,
    6. Zhang FK,
    7. et al.

    (2015) Toxoplasma gondii infection in cancer patients: Prevalence, risk factors, genotypes, and association with clinical diagnosis. Cancer Letters 359:307–313.

    OpenUrlCrossRef
13. ↵
    1. Osthoff M,
    2. Chew E,
    3. Bajel A,
    4. Kelsey G,
    5. Hudson YP,
    6. Mason K,
    7. et al.

    (2013) Disseminated toxoplasmosis after allogeneic stem cell transplantation in a seronegative recipient. Transpl Infect Dis 15:e14–e19.

    OpenUrl
14. ↵
    1. Jancalek R,
    2. Novak Z,
    3. Chrastina J,
    4. Burkon P,
    5. Slana B,
    6. Feitova V

    (2011) Opportunistic infections in patients after complex therapy of cancer. Klin Onkol 24:46–49.

    OpenUrlPubMed
15. ↵
    1. Carey RM,
    2. Kimball AC,
    3. Armstrong D,
    4. Lieberman PH

    (1973) Toxoplasmosis: Clinical experience in a cancer hospital. Am J Med 54:30–38.

    OpenUrlCrossRefPubMedWeb of Science